240
Participants
Start Date
Not specified
Study Completion Date
October 31, 1997
Mexiletine hydrochloride
Benztropine mesylate
Amitriptyline hydrochloride
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Univ. of Rochester ACTG CRS, Rochester
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
Howard University Hosp., Div. of Infectious Diseases, ACTU, Washington D.C.
Johns Hopkins Adult AIDS CRS, Baltimore
Alabama Therapeutics CRS, Birmingham
Case CRS, Cleveland
Methodist Hosp. of Indiana, Indianapolis
Univ. of Iowa Healthcare, Div. of Infectious Diseases, Iowa City
Hennepin County Med. Ctr., Div. of Infectious Diseases, Minneapolis
University of Minnesota, ACTU, Minneapolis
Northwestern University CRS, Chicago
Cook County Hosp. CORE Ctr., Chicago
Rush Univ. Med. Ctr. ACTG CRS, Chicago
Weiss Memorial Hosp., Chicago
St. Louis ConnectCare, Infectious Diseases Clinic, St Louis
University of Colorado Hospital CRS, Aurora
UCLA CARE Center CRS, Los Angeles
Harbor-UCLA Med. Ctr. CRS, Torrance
Queens Med. Ctr., Honolulu
Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu
University of Washington AIDS CRS, Seattle
Unc Aids Crs, Chapel Hill
Univ. of Miami AIDS CRS, Miami
Univ. of Cincinnati CRS, Cincinnati
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr., Omaha
Ucsd, Avrc Crs, San Diego
Ucsf Aids Crs, San Francisco
The Ponce de Leon Ctr. CRS, Atlanta
Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans
Beth Israel Deaconess - East Campus A0102 CRS, Boston
Washington U CRS, St Louis
Mbeya Med. Research Program, Mbeya Referral Hosp. CRS, Mbeya
Massachusetts General Hospital ACTG CRS, Boston
Bmc Actg Crs, Boston
Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH